In “The Age of AI for Offensive Cyber,” IQT Senior Partner Katie Gray and co-author Maggie Gray explore how AI is fundamentally transforming how offensive cyber operations are conceived and executed. AI agents today are already capable of autonomously conducting reconnaissance, identifying vulnerabilities, and even deploying exploit code with minimal human input. This shift dramatically increases the speed and scale of cyber operations beyond what human operators alone could previously achieve.
With this change, we’re seeing an evolving U.S. government strategy where offensive cyber is moving from a behind-the-scenes capability to a recognized pillar of national security. Leaders are now openly discussing not only defending networks, but using cyber operations proactively to impose costs on adversaries.
Jenny Irvine, VP of Technology, spoke on trends in space investing alongside leading researchers in aerospace and aviation. The conference highlighted cutting-edge technical advances and sparked important conversations about how startups can plug into this ecosystem to translate research into mission impact. Learn more about Jenny’s insights below.
In a recent interview with Tectonic, Managing Partner A.J. Bertone shared how IQT’s model bridges government mission needs with venture speed. He discussed how close collaboration with public-sector partners shapes where we invest and how that alignment helps emerging technologies move from early promise to real operational value. Read the full conversation below.
The strength of U.S. manufacturing is once again a national security imperative. IQT is working with startups that combine AI-enabled production, advanced hardware, and engineered biology to restore the nation’s ability to design and build at home. These companies are shortening supply chains, reducing dependence on adversary nations, and giving operators equipment that can be delivered and upgraded at the pace of modern conflict.
From medicines to critical materials, engineering biology offers a path to produce what the nation needs without relying on unstable global markets. This two-part biotech blog series explores IQT’s Engineering Biology Toolkit and highlights the capabilities required to move discoveries into dependable production: better data to understand biology, smarter tools to design it, and scalable platforms to manufacture it. The impact reaches far beyond the lab with more resilient industries, healthier communities, and a stronger industrial base.
What does it look like when biology becomes infrastructure? In our latest podcast, IQT experts and leaders from portfolio companies Alta Resource Technologies and Antheia describe how biosynthesis can bring pharmaceutical ingredient production back to the United States and how protein-based processes can separate critical minerals with unprecedented precision. These advances point toward supply chains that are faster, cleaner, and far less vulnerable to disruption, as well as capabilities with direct consequences for both public health and national defense. Listen to the full conversation below!
Dec.17, 2025: “Radiant’s latest investment round advances a vision of portable nuclear power designed for the most demanding settings, from remote installations to disaster response. Dependable energy underpins every modern capability, and Radiant’s progress moves the U.S. closer to power sources that are secure, transportable, and independent of vulnerable fuel logistics.”
Across every domain, from cyber and biotech to energy and manufacturing, the common thread is mission impact: technologies that strengthen the people and systems protecting the nation. Thank you for being part of the IQT community.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.